KAKenta Arai

Kenta Arai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kenta Arai has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • From Folding Reagents to Catalysts: Spatially Organized Diselenide−Cyclodextrins Enable Catalytic Oxidative Protein Folding

    by Yuki Iwata, Shunpei Iwamoto, Hiroki Takeda, Kenta Arai

    Oxidative folding, involving disulfide (SS) bond formation and isomerization, is essential for the maturation of many secreted and membrane proteins. Although numerous small-molecule mimics of protein disulfide isomerase, a key enzyme that catalyzes oxidative folding, have been developed, most require superstoichiometric amounts relative to the substrate. Here, we report cyclodextrin (CD)diselenide conjugates that create artificial folding reaction fields by spatially integrating substrate capture with redox catalysis within a topology-preserving bivalent architecture. Systematic variation of CD size, substitution pattern, and linker structure identified a γ-CDcyclic diselenide conjugate bearing two hydrophobic inclusion sites as the most effective catalyst across multiple model proteins. Mechanistic studies suggest that this bivalent architecture maintains a multivalent substrate-capture environment throughout the redox cycle, organizing protein thiols and mispaired SS bonds near the redox center to promote both SS formation and isomerization while suppressing aggregation. This reaction-field design transforms conventional folding reagents into true catalysts and establishes a molecular design principle for catalytic oxidative protein folding and the efficient production of SS-rich proteins.

  • Open Access

    Beyond Folding Enzymes: A Redox-Active “Solid Chaperone” Unlocks Recyclable, HPLC-Free Oxidative Protein Folding

    by Shunpei Iwamoto, Yuya Nishizawa, Hayato Yokose, Osamu Kanie, Yosuke Okamura, Takahiro Muraoka, Kenta Arai

    Oxidative protein folding, which is critical to proteins achieving their functional structures, is catalyzed in cells by protein disulfide isomerase (PDI)an enzyme that couples redox catalysis with the transient capture of folding intermediates to promote native disulfide formation while preventing aggregation. Although PDI improves oxidative folding in both chemically synthesized and recombinantly produced proteins, its use is restricted to homogeneous systems, limiting reusability and operational robustness. Artificial PDI mimics have advanced in vitro folding; however, no system has yet combined sufficient redox activity for native disulfide formation with a folding environment that suppresses aggregation, nor demonstrated true reusability. Here, we introduce a polymer-based “solid chaperone” that realizes PDI-like dual activity on an abiotic surface, achieving what natural PDI cannot: recyclable, HPLC-free oxidative folding without the stability and single-use limitations of enzymes. The covalent immobilization of cyclic diselenide onto polystyrene beads yields a redox-active and hydrophobic interface that transiently captures unfolded proteins, catalyzes both disulfide bond formation and isomerization, and suppresses aggregation even at high substrate concentrations. This solid-phase catalyst outperformed its homogeneous counterpart, producing native peptides and proteins in up to 99% yield and retaining full activity over multiple reuse cycles. These results demonstrate that complex biological folding functions, once confined to fragile enzymes, can be re-engineered into durable polymeric materials. This solid-phase strategy not only enables recyclable oxidative folding but also establishes a paradigm for translating enzymatic behavior into scalable synthetic systems with industrial potential.


  • Open Access

    An Initiator-Free Electrochemical Approach to Radical Thiol–Ene Coupling in a Microfluidic Reactor

    by Kakeru Yamamoto, Kenta Arai

    The anti-Markovnikov addition of thiyl radicals, generated via one-electron oxidation of thiols, to C=C double bonds is a useful method for synthesizing unsymmetrical sulfides and has been widely applied in the preparation of pharmaceuticals and functional materials. However, conventional radical thiol–ene reactions require metal-based photoinitiators or organic photosensitizers, raising concerns about product isolation and environmental impact. Herein, we demonstrate an initiator-free thiol–ene coupling via electrochemical oxidation of thiols. Using a microfluidic electrochemical reactor, the electrochemically generated thiyl radicals undergo rapid and selective addition to alkenes, affording thioethers in reasonable yields. Substrate scope studies involving 13 alkenes and 13 thiols indicate that thiol acidity (pKa), alkene electronic properties, and steric effects play key roles in determining reaction efficiency. Although further optimization is required to improve yields and broaden substrate scope, this electrochemical approach highlights the potential of thiol–ene coupling as a sustainable tool in green synthetic chemistry.


  • Open Access

    Ca2+-triggered allosteric catalysts crosstalk with cellular redox systems through their foldase- and reductase-like activities

    by Rumi Mikami, Yuhei Sato, Shingo Kanemura, Takahiro Muraoka, Masaki Okumura, Kenta Arai

    Effective chemical catalysts can artificially control intracellular metabolism. However, in conventional catalytic chemistry, activity and cytotoxicity have a trade-off relationship; thus, driving catalysts in living cells remains challenging. To overcome this critical issue at the interface between catalytic chemistry and biology, we developed cell-driven allosteric catalysts that exert catalytic activity at specific times. The synthesized allosteric redox catalysts up- and downregulated their foldase- and antioxidase-like activities in response to varying Ca2+ concentrations, which is a key factor for maintenance of the redox status in cells. In the absence of Ca2+ or at low Ca2+ concentrations, the compounds were mostly inactive and hence did not affect cell viability. In contrast, under specific conditions with elevated cytosolic Ca2+ concentrations, the activated compounds resisted the redox imbalance induced by the reactive oxygen species generated by Ca2+-stimulated mitochondria. Smart catalysts that crosstalk with biological phenomena may provide a platform for new prodrug development guidelines.


  • ER Oxidoreductin 1‐Like Activity of Cyclic Diselenides Drives Protein Disulfide Isomerase in an Electron Relay System

    by Rumi Mikami, Yuya Nishizawa, Yuki Iwata, Shingo Kanemura, Masaki Okumura, Kenta Arai

    Disulfide formation generally involves a two‐electron oxidation reaction between cysteine residues. Additionally, disulfide formation is an essential post‐translational modification for the structural maturation of proteins. This oxidative folding is precisely controlled by an electron relay network constructed by protein disulfide isomerase (PDI), with a CGHC sequence as the redox‐active site, and its family enzymes. Creating reagents that mimic the functions of these enzymes facilitates folding during chemical protein synthesis. In this study, we aimed to imitate a biological electron relay system using cyclic diselenide compounds as surrogates for endoplasmic reticulum oxidoreductin 1 (Ero1), which is responsible for the re‐oxidation of PDI. Oxidized PDI (PDIox) introduces disulfide bonds into substrate proteins, resulting in its conversion to reduced PDI (PDIred). The PDIred is then re‐oxidized to PDIox by a coexisting cyclic diselenide compound, thereby restoring the function of PDI as a disulfide‐forming agent. The produced diselenol state is readily oxidized to the original diselenide state with molecular oxygen, continuously sustaining the PDI catalytic cycle. This artificial electron relay system regulating enzymatic PDI function effectively promotes the oxidative folding of disulfide‐containing proteins, such as insulin – a hypoglycemic formulation – by enhancing both yield and reaction velocity.


  • Open Access

    Seleno-relaxin analogues: effect of internal and external diselenide bonds on the foldability and a fibrosis-related factor of endometriotic stromal cells

    by Yuri Satoh, Yosuke Ono, Rikana Takahashi, Hidekazu Katayama, Michio Iwaoka, Osamu Yoshino, Kenta Arai

    The [C11UA,C11UB] and [C10UA,C15UA] variants of human relaxin-2, which were synthesized via a one-pot assembly of the component A- and B-chains, efficiently reduced the expression of a tissue fibrosis-related factor in endometriotic stromal cells.


  • Open Access

    Boosting the enzymatic activity of CxxC motif-containing PDI family members

    by Tsubura Kuramochi, Yukino Yamashita, Kenta Arai, Shingo Kanemura, Takahiro Muraoka, Masaki Okumura

    Compounds harboring high acidity and oxidizability of thiol groups permit tuning the redox equilibrium constants of CxxC sites of the PDI family enzymes and thus can be used to promote oxidative folding and increase the native protein productions by minimal loading as compared to glutathione.


  • Open Access

    Diselenide-bond replacement of the external disulfide bond of insulin increases its oligomerization leading to sustained activity

    by Kenta Arai, Masaki Okumura, Young-Ho Lee, Hidekazu Katayama, Kenji Mizutani, Yuxi Lin, Sam-Yong Park, Kaichiro Sawada, Masao Toyoda, Hironobu Hojo, et al.

    Seleno-insulin, a class of artificial insulin analogs, in which one of the three disulfide-bonds (S-S’s) of wild-type insulin (Ins) is replaced by a diselenide-bond (Se-Se), is attracting attention for its unique chemical and physiological properties that differ from those of Ins. Previously, we pioneered the development of a [C7UA,C7UB] analog of bovine pancreatic insulin (SeIns) as the first example, and demonstrated its high resistance against insulin-degrading enzyme (IDE). In this study, the conditions for the synthesis of SeIns via native chain assembly (NCA) were optimized to attain a maximum yield of 72%, which is comparable to the in vitro folding efficiency for single-chain proinsulin. When the resistance of BPIns to IDE was evaluated in the presence of SeIns, the degradation rate of BPIns became significantly slower than that of BPIns alone. Furthermore, the investigation on the intermolecular association properties of SeIns and BPIns using analytical ultracentrifugation suggested that SeIns readily forms oligomers not only with its own but also with BPIns. The hypoglycemic effect of SeIns on diabetic rats was observed at a dose of 150 μg/300 g rat. The strategy of replacing the solvent-exposed S-S with Se-Se provides new guidance for the design of long-acting insulin formulations.


  • Resin-supported cyclic telluride as a heterogeneous promoter of disulfide formation under solid–liquid biphasic conditions

    by Yuya Nishizawa, Yuri Satoh, Osamu Kanie, Kenta Arai

    The oxidative crosslinking of thiols via a disulfide (SS) bond is a fundamental chemical reaction in the industrial production of protein- and peptide-based formulations. In this study, we developed a new heterogeneous catalyst/mediator, polystyrene-resin-immobilized cyclic telluride [(S)-tetrahydrotellurophen-3-amine] (RSTe), which significantly promotes the oxidation of thiols to disulfides (SS formation). Under solid–liquid biphasic reaction conditions, RSTe exhibited glutathione-peroxidase-like activity in the oxidative SS formation of 15 organic solvent- and water-soluble thiols using a peroxide (H2O2 or tBuOOH) as an oxidant. Notably, all reactions were completed within 90 min, and RSTe and the peroxide could be removed by filtration and concentration, respectively, thereby affording the target disulfides in sufficient yield and purity without further purification. This reaction system could also be utilized for SS formation in cysteine-containing polypeptide chains, suggesting the potential application of RSTe in oxidative folding, which is an essential process in the production of bioactive proteins.


  • Open Access

    Semi-enzymatic acceleration of oxidative protein folding by N-methylated heteroaromatic thiols

    by Shunsuke Okada, Yosuke Matsumoto, Rikana Takahashi, Kenta Arai, Shingo Kanemura, Masaki Okumura, Takahiro Muraoka

    We report the first example of a synthetic thiol-based compound that promotes oxidative protein folding upon 1-equivalent loading to the disulfide bonds in the client protein to afford the native form in over 70% yield. N-Methylation is a central post-translational processing of proteins in vivo for regulating functions including chaperone activities. Despite the universally observed biochemical reactions in nature, N-methylation has hardly been utilized in the design, functionalization, and switching of synthetic bioregulatory agents, particularly folding promotors. As a biomimetic approach, we developed pyridinylmethanethiols to investigate the effects of N-methylation on the promotion of oxidative protein folding. For a comprehensive study on the geometrical effects, constitutional isomers of pyridinylmethanethiols with ortho-, meta-, and para-substitutions have been synthesized. Among the constitutional isomers, para-substituted pyridinylmethanethiol showed the fastest disulfide-bond formation of the client proteins to afford the native forms most efficiently. N-Methylation drastically increased the acidity and enhanced the oxidizability of the thiol groups in the pyridinylmethanethiols to enhance the folding promotion efficiencies. Among the isomers, para-substituted N-methylated pyridinylmethanethiol accelerated the oxidative protein folding reactions with the highest efficiency, allowing for protein folding promotion by 1-equivalent loading as a semi-enzymatic activity. This study will offer a novel bioinspired molecular design of synthetic biofunctional agents that are semi-enzymatically effective for the promotion of oxidative protein folding including biopharmaceuticals such as insulin in vitro by minimum loading.